European regulator gives green light for Astra-Oxford COVID-19 vaccine

AMSTERDAM (Reuters) - Europe's medicines regulator on Friday approved AstraZeneca and Oxford University's COVID-19 vaccine for people over the age of 18, the third vaccine to be cleared for use in the European Union.

Reuters January 30, 2021 00:10:56 IST
European regulator gives green light for Astra-Oxford COVID-19 vaccine

COVID-19 vaccine" src="https://images.firstpost.com/wp-content/uploads/reuters/01-2021/30/2021-01-29T153451Z_1_LYNXMPEH0S184_RTROPTP_2_HEALTH-CORONAVIRUS-BRITAIN-VACCINE.jpg" alt="European regulator gives green light for AstraOxford COVID19 vaccine" width="300" height="225" />

AMSTERDAM (Reuters) - Europe's medicines regulator on Friday approved AstraZeneca and Oxford University's COVID-19 vaccine for people over the age of 18, the third vaccine to be cleared for use in the European Union.

The AstraZeneca vaccine demonstrated an efficacy of around 60% in the trials on which the decision was based, the European Medicines Agency (EMA) said in a statement https://bit.ly/3pwGYlx.

“With this third positive opinion, we have further expanded the arsenal of vaccines available to EU and EEA member states to combat the pandemic and protect their citizens,” said Emer Cooke, Executive Director of EMA.

Europe urgently needs more shots to speed up its inoculation programme with suppliers such as AstraZeneca, Pfizer and Moderna facing difficulties in delivering the quantities promised for the early months of the year.

There were not yet enough results for people over the age of 55 to determine how well the vaccine would work for this group, EMA said. However, it said protection was expected and that the vaccine can be given to older people.

AstraZeneca CEO Pascal Soriot welcomed the decision.

"Today’s recommendation underscores the value of AstraZeneca’s COVID-19 vaccine which is not only effective and well-tolerated, but also easy to administer and, importantly, protects fully against severe disease and hospitalisations," he said in a statement.

The AstraZeneca vaccine is administered via two injections into the arm, the second between 4 and 12 weeks after the first.

The European Union last year agreed to buy up to 400 million doses of the vaccine.

Concerns over its value for the elderly were raised on Thursday when Germany's vaccine committee said it should be given only to people aged between 18 and 64, due to a lack of data about how effective it is in older people.

(Writing by Pushkala Aripaka in Bengaluru, Editing by Douglas Busvine, Keith Weir and Elaine Hardcastle)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Subscribe to Moneycontrol Pro at ₹499 for the first year. Use code PRO499. Limited period offer. *T&C apply

also read

Thyssenkrupp ends talks with UK's Liberty on steel unit sale
Business

Thyssenkrupp ends talks with UK's Liberty on steel unit sale

By Christoph Steitz, Tom Käckenhoff and Arno Schuetze FRANKFURT (Reuters) - German conglomerate Thyssenkrupp ended talks to sell its steel division to Britain's Liberty Steel due to differences over value, the latest setback in efforts to consolidate the European sector. Liberty Steel, led by commodities tycoon Sanjeev Gupta, last month submitted a firmed-up non-binding bid for Thyssenkrupp's steel unit, Europe's second biggest in terms of sales, which sources said included commitments to protect jobs and sites.

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo
Business

Factbox: Stonks in Washington: Deciphering Reddit's WallStreetBets lingo

(Reuters) - Reddit trading lingo may filter in to Washington on Thursday when top hedge fund managers, the head of Robinhood and Roaring Kitty himself are set to give testimony before U.S. House of Representatives lawmakers.

Brent gives up gains after rising above $65 on Texas freeze
Business

Brent gives up gains after rising above $65 on Texas freeze

By Stephanie Kelly NEW YORK (Reuters) - Oil prices steadied on Thursday, with Brent edging back from a 13-month high, after a sharp drop in U.S. crude inventories supported prices, while buying spurred by a cold snap in the largest U.S. energy-producing state petered out.